Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

Is the current ratio high or low?

The current ratio of 4.42 is 20% above its 5-year average of 3.67, near the high end of its 5-year range (3.01–4.68).

As of Sunday, June 28, 2026. 3.88% above its 12-month average of 4.26.

Quick Ratio|Debt to Equity|P/B Ratio|All Metrics
Current Ratio

EW Current Ratio

4.42

Reported quarterly current ratio; no daily interpolation.

+17.90% 5Y
EW Current Ratio

EW Average Current Ratio Chart

EW Current Ratio

EW Current vs Average Current Ratio Chart

EW Current Ratio Metrics

CURRENT RATIO

4.42

CURRENT RATIO AVG TTM

4.26

CURRENT RATIO AVG 3Y

3.78

CURRENT RATIO AVG 5Y

3.62

CURRENT RATIO AVG 10Y

3.60

CURRENT RATIO AVG 15Y

3.82

CURRENT RATIO AVG 20Y

3.52

CURRENT VS TTM AVG

+3.88%

CURRENT VS 3Y AVG

+16.81%

CURRENT VS 5Y AVG

+22.01%

CURRENT VS 10Y AVG

+22.63%

CURRENT VS 15Y AVG

+15.62%

CURRENT VS 20Y AVG

+25.63%

EW Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
Edwards Lifesciences Corporation (EW)$52.27B4.424.263.783.62
Cencora, Inc. (COR)vs ›$55.67B0.900.890.890.92
Cardinal Health, Inc. (CAH)vs ›$55.72B0.940.961.001.04
Becton, Dickinson and Company (BDX)vs ›$56.49B1.111.141.161.25
Humana Inc. (HUM)vs ›$46.08B0.720.580.570.58
IDEXX Laboratories, Inc. (IDXX)vs ›$43.50B1.171.241.231.33
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$65.20B4.134.434.904.47
Boston Scientific Corporation (BSX)vs ›$65.74B1.621.351.381.47
Agilent Technologies, Inc. (A)vs ›$38.41B1.962.022.172.21
Medline Inc. (MDLN)vs ›$32.87B4.293.843.943.94

Liquidity Analysis

Current Ratio

4.42

Quick Ratio

3.09

Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Current Ratio FAQ

What is the current ratio for Edwards Lifesciences Corporation (EW)?
The current ratio for EW stock is 4.42.
Is Edwards Lifesciences Corporation's current ratio high or low?
The current ratio of 4.42 is 20% above its 5-year average of 3.67, near the high end of its 5-year range (3.01–4.68).
What is the TTM average current ratio for Edwards Lifesciences Corporation (EW)?
The TTM average current ratio for EW stock is 4.26.
What is the 3Y average current ratio for Edwards Lifesciences Corporation (EW)?
The 3Y average current ratio for EW stock is 3.78.
What is the 5Y average current ratio for Edwards Lifesciences Corporation (EW)?
The 5Y average current ratio for EW stock is 3.62.
What is the 10Y average current ratio for Edwards Lifesciences Corporation (EW)?
The 10Y average current ratio for EW stock is 3.60.
What is the 15Y average current ratio for Edwards Lifesciences Corporation (EW)?
The 15Y average current ratio for EW stock is 3.82.
What is the 20Y average current ratio for Edwards Lifesciences Corporation (EW)?
The 20Y average current ratio for EW stock is 3.52.

EW Current Ratio History

DATECURRENT RATIO
2026-03-314.42
2025-12-313.72
2025-09-304.00
2025-06-304.68
2025-03-314.45
2024-12-314.18
2024-09-303.46
2024-06-303.71
2024-03-313.75
2023-12-313.38
2023-09-303.28
2023-06-303.15
2023-03-313.01
2022-12-313.03
2022-09-303.83
2022-06-303.37
2022-03-313.41
2021-12-313.08
2021-09-303.64
2021-06-303.75
2021-03-313.84
2020-12-313.46
2020-09-303.52
2020-06-303.08
2020-03-313.36
2019-12-313.31
2019-09-303.53
2019-06-303.38
2019-03-313.66
2018-12-312.61
2018-09-302.31
2018-06-302.28
2018-03-312.07
2017-12-311.81
2017-09-303.49
2017-06-304.06
2017-03-313.45
2016-12-314.21
2016-09-304.08
2016-06-304.15
2016-03-313.97
2015-12-314.30
2015-09-304.03
2015-06-305.16
2015-03-315.56
2014-12-315.28
2014-09-305.40
2014-06-304.21
2014-03-314.50
2013-12-314.99
2013-09-304.69
2013-06-304.43
2013-03-314.53
2012-12-313.72
2012-09-304.65
2012-06-304.50
2012-03-314.48
2011-12-313.49
2011-09-303.91
2011-06-303.88
2011-03-312.58
2010-12-313.06
2010-09-303.52
2010-06-303.71
2010-03-313.60
2009-12-313.06
2009-09-303.06
2009-06-303.04
2009-03-313.24
2008-12-312.68
2008-09-302.94
2008-06-302.80
2008-03-311.51
2007-12-311.55
2007-09-301.62
2007-06-301.67
2007-03-313.02
2006-12-312.35
2006-09-302.31
2006-06-302.39
2006-03-312.67
2005-12-312.65
2005-09-302.10
2005-06-302.30
2005-03-312.27
2004-12-311.88
2004-09-301.92
2004-06-302.14
2004-03-312.09
2003-12-312.15
2003-09-302.14
2003-06-302.09
2003-03-311.85
2002-12-311.65
2002-09-301.70
2002-06-301.67

Related Metrics

Quick RatioDebt to EquityP/B RatioAll Metrics

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
www.edwards.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
View full financials